Farnesoid X receptor is essential for normal glucose homeostasis
about
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic controlBile acids: regulation of apoptosis by ursodeoxycholic acidForkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed miceThe blind men 'see' the elephant-the many faces of fatty liver diseaseRole of bile acids in the regulation of the metabolic pathwaysNovel bile acid therapeutics for the treatment of chronic liver diseasesGut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of MetabolomicsObesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic SyndromeBile acid receptors and nonalcoholic fatty liver diseaseBile acids: emerging role in management of liver diseasesBile acid metabolism and signalingBile acids, obesity, and the metabolic syndromeThe gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseasesIdentification of a potent synthetic FXR agonist with an unexpected mode of binding and activationThe antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolismBile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver DiseaseRole of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the LiteratureBile acid nuclear receptor FXR and digestive system diseasesRole of farnesoid X receptor and bile acids in alcoholic liver diseaseDiacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytesThe nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicityFXR is a molecular target for the effects of vertical sleeve gastrectomyBile acid signaling in metabolic disease and drug therapyFarnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasisFarnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulationRole of nuclear receptor SHP in metabolism and cancer.Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASHThe farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolismCoordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 DiabetesBile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor αFarnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.Bile acid sequestrants for lipid and glucose control.Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor.FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.The artificial sweetener acesulfame potassium affects the gut microbiome and body weight gain in CD-1 mice.A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibitionCharacterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model
P2860
Q24629879-08547447-A177-43F5-BB6C-61E16395392DQ24653969-D1640F7E-3881-497D-B8AE-B3BFEC6752A5Q24654808-05A14EDC-9D8D-42BD-9068-E8C8AAA0C96CQ24654991-59B34432-747A-4271-9AF3-4C6D8623AD3DQ26738976-504A4B3C-C08C-4F17-8587-885248BF6E5AQ26748613-BC696FC4-AB7D-424F-B5D3-0D0B06B8B22EQ26753047-5E1EABB4-CED5-478E-87EC-A99472D45852Q26774779-E530CFE0-7C86-4E1E-B6B0-42A768C0E92CQ26775814-21B53D44-3783-4266-8553-1D210A509663Q26796318-E69CC0FB-CF61-4DBF-9DDB-5570108883A6Q27002873-74026866-4BFE-45E1-963C-E9E8F1D2E906Q27020976-BC190DE6-66C8-40E5-A277-73E3F3FBC06DQ27021692-22C8DF92-2F27-40C6-AA75-20E1DCCBFB65Q27650237-F73D9477-7588-4B38-89E3-1BFC5AD6F059Q27684737-5CB33386-3919-4FED-B421-2046B91CD151Q28076064-737F0131-0E25-4F82-9FC2-AB7B7055831DQ28079131-070A358D-EFC1-4365-951F-7A4D6A5EC417Q28085493-72EA4BC6-CC1C-47F4-8934-A29C113D3899Q28086898-557895BD-3667-4DA2-9945-F7B4EC0E4ABDQ28114796-A2DFA74C-7A18-4142-8882-0044D1127AA5Q28118770-DCDE8EAB-E2C9-4C62-9823-B89AE79CABA6Q28236848-15628A26-9E86-45D5-9653-28CB8B6D0BD9Q28244875-A12B7A42-DEAF-4840-9B3E-FCE5146AD319Q28253815-38DFFA52-2FE8-4567-8330-948B191F5201Q28581627-F2559D88-84BF-45FE-BECB-05FA7F03F599Q30395192-7AAE24F0-F0A4-490B-B141-64D24A05D2C4Q30454451-49EC4531-8A9E-4B80-A4AC-7C47E9CB7576Q33570124-E66C4F59-9B57-4E4C-9B1A-6BC5A5BE3C78Q33579464-37D72E5D-7F47-4966-85DE-8ABD43698C32Q33608251-EF33C6A7-B1EF-480E-8EE8-3CE4EA3A9040Q33610738-3BA88486-69C2-4373-991F-89867BEAD38EQ33636948-96FC4B60-93FB-469D-AEA6-72DC9A5D9E52Q33642712-D10D708E-2BF8-49AC-BED7-0795343772C1Q33651272-3848C554-5BF6-4A72-8F08-32EC3556E5A9Q33661459-17A781B6-EDA8-4AF9-B9A1-462A432B722CQ33693402-6F45610E-85DF-4C15-9971-EBF4E02DA1A6Q33741191-1450F6C6-3778-4A90-9BF9-68355D230211Q33778259-3E22A05B-8E0B-405B-AB57-ED3BCEC3DBF3Q33800237-8E984CEF-37B8-4047-801D-59812AEF0890Q33828259-07D04E5B-0607-43C9-AFB6-08B584D10563
P2860
Farnesoid X receptor is essential for normal glucose homeostasis
description
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im April 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/04/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/04/01)
@nl
наукова стаття, опублікована у квітні 2006
@uk
مقالة علمية (نشرت في أبريل 2006)
@ar
name
Farnesoid X receptor is essential for normal glucose homeostasis
@ast
Farnesoid X receptor is essential for normal glucose homeostasis
@en
Farnesoid X receptor is essential for normal glucose homeostasis
@nl
type
label
Farnesoid X receptor is essential for normal glucose homeostasis
@ast
Farnesoid X receptor is essential for normal glucose homeostasis
@en
Farnesoid X receptor is essential for normal glucose homeostasis
@nl
prefLabel
Farnesoid X receptor is essential for normal glucose homeostasis
@ast
Farnesoid X receptor is essential for normal glucose homeostasis
@en
Farnesoid X receptor is essential for normal glucose homeostasis
@nl
P2093
P2860
P3181
P356
P1476
Farnesoid X receptor is essential for normal glucose homeostasis
@en
P2093
David D. Moore
Lawrence Chan
Pradip K. Saha
P2860
P304
P3181
P356
10.1172/JCI25604
P407
P577
2006-04-01T00:00:00Z